82 results
Page 3 of 5
8-K
EX-99.1
uz3usr nob6
29 Mar 21
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
5:26pm
424B5
j3m 4jq072
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
yjpkfi7vohj3y5k
22 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.1
7tfp2j119y46ell vseq
16 Nov 20
Windtree Therapeutics Reports Third Quarter 2020
7:40am
8-K
EX-99.1
9k882hs12vwhru4gi
1 Oct 20
Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
7:36am
8-K
EX-99.1
94ovx7 rarn0vhw
29 Sep 20
Other Events
7:37am
8-K
EX-99.1
rq3a5mv1
14 Aug 20
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
6:07am
8-K
EX-99.2
2wnzvyx2wxxzrtivu
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-99.1
3dsj4tpg
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
424B4
qfbxnwkb2
21 May 20
Prospectus supplement with pricing info
6:04am
8-K
EX-99.1
9ymh5apdysked1veqh
14 May 20
Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
8:12am